{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "SEK", "exchange": "STO", "shortName": "AlzeCure Pharma AB", "longName": "AlzeCure Pharma AB (publ)", "messageBoardId": "finmb_529248112", "market": "se_market", "marketState": "REGULAR", "earningsTimestamp": 1683284340, "earningsTimestampStart": 1683284340, "earningsTimestampEnd": 1683284340, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.0, "epsForward": -1.69, "sharesOutstanding": 62087000, "bookValue": 0.974, "fiftyDayAverage": 4.4728, "fiftyDayAverageChange": 0.107200146, "fiftyDayAverageChangePercent": 0.023967125, "twoHundredDayAverage": 4.270902, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Europe/Stockholm", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": 4.090905, "regularMarketPrice": 4.58, "regularMarketChange": 0.17999983, "regularMarketTime": 1684143888, "regularMarketDayHigh": 4.67, "regularMarketDayRange": "4.23 - 4.67", "regularMarketDayLow": 4.23, "regularMarketVolume": 18091, "regularMarketPreviousClose": 4.4, "bid": 4.49, "ask": 4.67, "bidSize": 0, "askSize": 0, "fullExchangeName": "Stockholm", "financialCurrency": "SEK", "regularMarketOpen": 4.4, "averageDailyVolume3Month": 40860, "averageDailyVolume10Day": 22736, "fiftyTwoWeekLowChange": 2.58, "fiftyTwoWeekLowChangePercent": 1.29, "fiftyTwoWeekRange": "2.0 - 6.2", "fiftyTwoWeekHighChange": -1.6199999, "fiftyTwoWeekHighChangePercent": -0.2612903, "fiftyTwoWeekLow": 2.0, "fiftyTwoWeekHigh": 6.2, "twoHundredDayAverageChange": 0.30909777, "twoHundredDayAverageChangePercent": 0.07237294, "marketCap": 299222848, "forwardPE": -2.710059, "priceToBook": 4.7022586, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "firstTradeDateMilliseconds": 1543392000000, "priceHint": 4, "symbol": "ALZCUR.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "H\u00e4lsov\u00e4gen 7", "address2": "Floor 7 Novum, Elevator D", "city": "Huddinge", "zip": "141 57", "country": "Sweden", "phone": "46 7 63 16 24 77", "website": "https://www.alzecurepharma.se", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "AlzeCure Pharma AB (publ), a pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is developing drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its pipeline products include ACD856, which is in phase I clinical trial to treat Alzheimer's disease, sleep disorders, traumatic brain injuries, and Parkinson's disease; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer's disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain; and TrkA-NAM for osteoarthritic pain. The company was founded in 2012 and is based in Huddinge, Sweden.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Mr. Martin  J\u00f6nsson", "age": 54, "title": "Chief Exec. Officer", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 2414000, "fmt": "2.41M", "longFmt": "2,414,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Birgitta  Lundvik", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Johan  Sandin", "age": 52, "title": "Chief Scientific Officer", "yearBorn": 1970, "fiscalYear": 2019, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Marta Segerdahl Storck M.D., Ph.D.", "age": 66, "title": "Chief Medical Officer & Head of Devel.", "yearBorn": 1956, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Pontus  Forsell", "age": 55, "title": "Head of Research & Discovery", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}